tiprankstipranks
Trending News
More News >
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market

Alaunos Therapeutics (TCRT) Income Statement

Compare
679 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q4 2024), Alaunos Therapeutics's total revenue was $4.00K, an increase of 300.00% from the same quarter last year. In Q4, Alaunos Therapeutics's net income was $-742.00K. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.00K$ 5.00K$ 2.92M$ 398.00K$ 0.00
Gross Profit
$ 10.00K$ -4.80M$ 163.00K$ -342.00K$ -1.13M
Operating Expenses
$ 4.82M$ 29.47M$ 38.16M$ 77.21M$ 80.36M
Depreciation and Amortization
$ 2.00K$ 2.31M$ 2.76M$ 2.60M$ 1.13M
EBITDA
$ -4.68M$ -30.90M$ -31.82M$ -74.97M$ -78.85M
Operating Income
$ -4.81M$ -34.27M$ -35.10M$ -77.55M$ -80.36M
Other Income/Expenses
$ 133.00K$ -873.00K$ -2.63M$ -1.20M$ 385.00K
Pretax Income
$ -4.68M$ -35.14M$ -37.73M$ -78.75M$ -79.98M
Net Income
$ -4.68M$ -35.14M$ -37.60M$ -76.89M$ -78.85M
Per Share Metrics
Basic EPS
$ -2.92$ -21.97$ -25.97$ -53.80$ -56.42
Diluted EPS
$ -2.92$ -21.97$ -25.97$ -53.80$ -56.42
Weighted Average Shares Outstanding
1.60M 1.60M 1.45M 1.43M 1.40M
Weighted Average Shares Outstanding (Diluted)
1.60M 1.60M 1.45M 1.43M 1.40M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis